UBS Global Life Sciences Conference Opens in New York

NEW YORK--(BUSINESS WIRE)-- The UBS Global Life Sciences Conference opens today at the Grand Hyatt in New York City and runs through Wednesday, September 22. The annual UBS Global Life Sciences Conference is among the largest health care investor conferences in the world. Senior executives from the leading pharmaceutical, biotechnology and medical technology companies will provide their insight and outlook on the global life sciences industry. More than 2,000 people are expected to attend. Presenting companies include:

   
Actelion DENTSPLY International PerkinElmer, Inc.
Agilent Technologies, Inc. DiaSorin QIAGEN N.V.
Alere Inc. Dr. Reddy's Laboratories Regeneron Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc F. Hoffmann-La Roche Ltd. ResMed
Allergan, Inc. Genoptix, Inc. Shanghai Fosun Pharma Group
Amgen Inc. Genzyme Corporation Sigma-Aldrich Corporation
Baxter Gilead Sciences, Inc. Sino Biopharmaceutical Ltd.
Bayer AG H. Lundbeck A/S Sirona Dental Systems, Inc.
Biogen Idec Henry Schein, Inc. Smith & Nephew
BioMarin Pharmaceutical Inc. Human Genome Sciences, Inc. STERIS Corporation
BioMed Realty Trust, Inc. Illumina, Inc. Teva Pharmaceutical Industries Ltd.
BioMerieux SA Life Technologies Thermo Fisher Scientific
Bristol-Myers Squibb Company Medtronic Inc. Thoratec Corporation
Celera Corporation Merck & Co., Inc. United Therapeutics Corporation
Celgene Corporation Merck KGaA Vertex Pharmaceuticals
Cephalon, Inc. Meridian Bioscience, Inc. Warner Chilcott
Cepheid Mettler-Toledo International, Inc. Waters Corporation
Charles River Laboratories Myriad Genetics, Inc. West Pharmaceutical Services, Inc.
China Shineway Pharmaceutical Novo Nordisk Inc.
Crucell Novozymes A/S
Danaher Corporation Pall Corporation
 
 

*This is a partial list of presenting companies. Companies subject to change. To access the agenda, please go to www.ibb.ubs.com/Conferences.

 

Audio transmissions and the conference agenda will be available on the UBS Investment Bank website at www.ibb.ubs.com/Conferences. Audio transmissions of company presentations will be available live and by replay. Replays will begin three hours after the actual presentation time and will be available on the site for up to four weeks.

UBS draws on its 150-year heritage to serve private, institutional and corporate clients worldwide, as well as retail clients in Switzerland. We combine our wealth management, investment banking and asset management businesses with our Swiss operations to deliver superior financial solutions and manage CHF 2.2 trillion in invested assets.

UBS is present in all major financial centers worldwide. It has offices in over 50 countries, with about 37% of its employees working in the Americas, 37% in Switzerland, 16% in the rest of Europe and 10% in Asia Pacific. UBS employs about 64,000 people around the world. Its shares are listed on the SIX Swiss Exchange and the New York Stock Exchange (NYSE).



CONTACT:

UBS
Kelly Smith, 212-882-5699
www.ubs.com

KEYWORDS:   United States  North America  New York

INDUSTRY KEYWORDS:   Health  Biotechnology  Pharmaceutical  Professional Services  Banking  Finance  Research  Science

MEDIA:

Logo
 Logo

Suggested Articles

All 12 members of an FDA advisory committee voted to recommend the approval of teprotumumab for a rare, autoimmune eye disease.

Early data out of former Fierce 15 winner Gritstone Oncology have been heralded as a big win for the early-stage biotech by analysts.

Biogen will drop work on gosuranemab in progressive supranuclear palsy but continue on in Alzheimer's.